News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
265 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21902)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (2)
2 (262)
3 (254)
4 (293)
5 (378)
6 (122)
7 (1)
8 (6)
9 (278)
10 (245)
11 (246)
12 (287)
13 (133)
15 (5)
16 (265)
17 (189)
18 (161)
19 (174)
20 (88)
21 (1)
22 (3)
23 (179)
24 (186)
25 (207)
26 (193)
27 (93)
28 (1)
29 (3)
30 (191)
31 (199)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Urethral Bulking System Market: Rising incidences of urinary continence among females is a major factor that is estimated to propel the market
Urethral bulking is used to treat urinary incontinence. It involves injecting material, such as collagen, around the urethra.
August 16, 2021
·
5 min read
Scleral Lens Market: Increase in awareness about scleral lens is attributed to the major share held by Asia Pacific
The two main types of materials of contact lenses are soft and hard or rigid. Scleral lens is a type of hard or rigid material contact lens, and it’s generally larger in diameter than other contact lenses.
August 16, 2021
·
5 min read
Preeclampsia Diagnostics Market: Increase in prevalence of pregnancy related diseases to drive the market
Preeclampsia is a hypertensive disorder of pregnancy and affects about 5% of pregnant women globally, out of whom 0.5% to 1% develop it in the severe form.
August 16, 2021
·
5 min read
Over-the-counter Pain Medication Market: R&D for combination drugs is a key growth strategy of large players in the market
The over-the-counter pain medication market is predicted to display notable growth over the forecast period from 2020 to 2030.
August 16, 2021
·
4 min read
Endoscope Washer-Disinfectors Market: Rise in number of endoscopic procedures to drive the market
Continuous advancements have been made in the design and functionality of endoscopes. A wide range of endoscopes are finding acceptance in clinical settings, such as in gastroenterology and hepatology.
August 16, 2021
·
5 min read
Pharm Country
Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2021
Amarin Corporation plc today announced that new data that add to the growing body of knowledge on VASCEPA®/VAZKEPA (icosapent ethyl) in patients at risk for major adverse cardiovascular events will be presented at ESC Congress 2021, organized by the European Society of Cardiology (ESC), being held virtually from August 27 – August 30, 2021.
August 16, 2021
·
13 min read
Business
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update
Teligent, Inc., a New Jersey-based generics pharmaceutical company, announced its financial results for the second quarter of 2021 and provided a business update.
August 16, 2021
·
10 min read
Drug Development
Travere Therapeutics Announces Positive Topline Interim Results from the Ongoing Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy
Travere Therapeutics, Inc. today announced positive topline interim results from the ongoing pivotal Phase 3 PROTECT Study of sparsentan, an investigational product candidate for the treatment of IgA nephropathy (IgAN).
August 16, 2021
·
12 min read
Business
atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update
atai Life Sciences N.V. today reported its financial results for the second quarter ended June 30, 2021 and provided a corporate update.
August 16, 2021
·
16 min read
Business
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2021
ESSA Pharma Inc. today provided a corporate update and reported financial results for the fiscal third quarter ended June 30, 2021 .
August 16, 2021
·
11 min read
Previous
22 of 27
Next